Low prevalence of interferon α autoantibodies in people experiencing symptoms of post–coronavirus disease 2019 (COVID-19) conditions, or long COVID

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - academic.oup.com
Interferon (IFN)–specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …
被引用次数：18 相关文章
[PDF] ucsf.edu

[PDF][PDF] Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post–Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - derisilab.ucsf.edu
Interferon (IFN)–specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post–Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - academic.oup.com
Interferon (IFN)–specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Interferon (IFN)-specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - pure.johnshopkins.edu
Interferon (IFN)-specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - europepmc.org
Interferon (IFN)-specific autoantibodies have been implicated in severe COVID-19 and have
been proposed as a potential driver of the persistent symptoms characterizing Long COVID …

Low Prevalence of Interferon-α Autoantibodies in People Experiencing Long COVID Symptoms

MJ Peluso, A Mitchell, CY Wang, S Takahashi… - The Journal of … - ncbi.nlm.nih.gov
Interferon (IFN)-specific autoantibodies have been implicated in severe COVID-19 and have
been proposed as a potential driver of the persistent symptoms characterizing Long COVID …

Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2023 - escholarship.org
Interferon (IFN)-specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low prevalence of interferon α autoantibodies in people experiencing symptoms of post-coronavirus disease 2019 (COVID-19) conditions, or long COVID.

MJ Peluso, A Mitchell, CY Wang, S Takahashi, R Hoh… - 2022 - cabidigitallibrary.org
Interferon (IFN)-specific autoantibodies have been implicated in severe coronavirus disease
2019 (COVID-19) and have been proposed as a potential driver of the persistent symptoms …

Low Prevalence of Interferon-α Autoantibodies in People Experiencing Long COVID Symptoms.

MJ Peluso, A Mitchell, CY Wang… - The Journal of …, 2022 - europepmc.org
Interferon (IFN)-specific autoantibodies have been implicated in severe COVID-19 and have
been proposed as a potential driver of the persistent symptoms characterizing Long COVID …